{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:42:08Z","timestamp":1782924128815,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70066-2","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:57:35Z","timestamp":1772207855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor metabolic adaptation induced by L-asparaginase reveals a vulnerability to PARP1\/2 inhibitor in B-cell lymphomas"],"prefix":"10.1038","volume":"17","author":[{"given":"Ana\u00efs","family":"Aussel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8080-839X","authenticated-orcid":false,"given":"Ivan","family":"Nemazanyy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashaina","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Meola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Dorat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Habbouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Exposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Nottet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8502-6979","authenticated-orcid":false,"given":"Virginie","family":"Petrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Mounier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8326-5730","authenticated-orcid":false,"given":"Sandrine","family":"Marchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Chaveroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1585-8117","authenticated-orcid":false,"given":"Jean-Ehrland","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5276-1125","authenticated-orcid":false,"given":"Johanna","family":"Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"key":"70066_CR1","first-page":"333","volume":"71","author":"DR Schmidt","year":"2021","unstructured":"Schmidt, D. R. et al. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J. Clin. 71, 333\u2013358 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"70066_CR2","doi-asserted-by":"crossref","unstructured":"Lemberg, K. M., Gori, S. S., Tsukamoto, T., Rais, R. & Slusher, B. S. Clinical development of metabolic inhibitors for oncology. J. Clin. Investig. 132, e148550 (2022).","DOI":"10.1172\/JCI148550"},{"key":"70066_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine, Z. E., Schug, Z. T., Salvino, J. M. & Dang, C. V. Targeting cancer metabolism in the era of precision oncology. Nat. Rev. Drug Discov. 21, 141\u2013162 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70066_CR4","doi-asserted-by":"crossref","unstructured":"Vasan, K. & Chandel, N. S. Molecular and cellular mechanisms underlying the failure of mitochondrial metabolism drugs in cancer clinical trials. J. Clin. Investig. 134, e176736 (2024).","DOI":"10.1172\/JCI176736"},{"key":"70066_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/sj.leu.2404216","volume":"20","author":"T Akagi","year":"2006","unstructured":"Akagi, T. et al. Methylation analysis of asparagine synthetase gene in acute lymphoblastic leukemia cells. Leukemia 20, 1303\u20131306 (2006).","journal-title":"Leukemia"},{"key":"70066_CR6","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1158\/1078-0432.CCR-18-1844","volume":"25","author":"A Touzart","year":"2019","unstructured":"Touzart, A. et al. Epigenetic silencing affects l-asparaginase sensitivity and predicts outcome in T-ALL. Clin. Cancer Res. 25, 2483\u20132493 (2019).","journal-title":"Clin. Cancer Res."},{"key":"70066_CR7","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1158\/1078-0432.CCR-14-1216","volume":"21","author":"C Kucuk","year":"2015","unstructured":"Kucuk, C. et al. Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Clin. Cancer Res. 21, 1699\u20131711 (2015).","journal-title":"Clin. Cancer Res."},{"key":"70066_CR8","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cmet.2019.02.002","volume":"29","author":"J Chiche","year":"2019","unstructured":"Chiche, J. et al. GAPDH expression predicts the response to R-CHOP, the tumor metabolic status, and the response of DLBCL patients to metabolic inhibitors. Cell Metab. 29, 1243\u20131257 e1210 (2019).","journal-title":"Cell Metab."},{"key":"70066_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn6491","volume":"8","author":"M Grima-Reyes","year":"2022","unstructured":"Grima-Reyes, M. et al. Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression. Sci. Adv. 8, eabn6491 (2022).","journal-title":"Sci. Adv."},{"key":"70066_CR10","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/s41556-019-0415-1","volume":"21","author":"G Pathria","year":"2019","unstructured":"Pathria, G. et al. Translational reprogramming marks adaptation to asparagine restriction in cancer. Nat. Cell Biol. 21, 1590\u20131603 (2019).","journal-title":"Nat. Cell Biol."},{"key":"70066_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ccell.2017.12.003","volume":"33","author":"DM Gwinn","year":"2018","unstructured":"Gwinn, D. M. et al. Oncogenic KRAS regulates amino acid homeostasis and asparagine biosynthesis via ATF4 and alters sensitivity to L-asparaginase. Cancer Cell 33, 91\u2013107 e106 (2018).","journal-title":"Cancer Cell"},{"key":"70066_CR12","doi-asserted-by":"publisher","first-page":"E7776","DOI":"10.1073\/pnas.1805523115","volume":"115","author":"A Nakamura","year":"2018","unstructured":"Nakamura, A. et al. Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response. Proc. Natl. Acad. Sci. USA 115, E7776\u2013E7785 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70066_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.htct.2019.07.010","volume":"42","author":"DK Cecconello","year":"2020","unstructured":"Cecconello, D. K. et al. Asparaginase: an old drug with new questions. Hematol. Transfus. Cell Ther. 42, 275\u2013282 (2020).","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"70066_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/bjh.16495","volume":"190","author":"V Mondelaers","year":"2020","unstructured":"Mondelaers, V. et al. Prospective, real-time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma in Belgium. Br. J. Haematol. 190, 105\u2013114 (2020).","journal-title":"Br. J. Haematol."},{"key":"70066_CR15","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1080\/10428194.2018.1542146","volume":"60","author":"RJ Schore","year":"2019","unstructured":"Schore, R. J. et al. Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children\u2019s Oncology Group AALL07P4. Leuk. Lymphoma 60, 1740\u20131748 (2019).","journal-title":"Leuk. Lymphoma"},{"key":"70066_CR16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1172\/JCI30235","volume":"117","author":"S Iwamoto","year":"2007","unstructured":"Iwamoto, S., Mihara, K., Downing, J. R., Pui, C. H. & Campana, D. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase. J. Clin. Investig. 117, 1049\u20131057 (2007).","journal-title":"J. Clin. Investig."},{"key":"70066_CR17","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1158\/0008-5472.CAN-12-4402","volume":"73","author":"EA Ehsanipour","year":"2013","unstructured":"Ehsanipour, E. A. et al. Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine. Cancer Res. 73, 2998\u20133006 (2013).","journal-title":"Cancer Res."},{"key":"70066_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00280-007-0421-z","volume":"60","author":"S Tardito","year":"2007","unstructured":"Tardito, S. et al. The inhibition of glutamine synthetase sensitizes human sarcoma cells to L-asparaginase. Cancer Chemother. Pharm. 60, 751\u2013758 (2007).","journal-title":"Cancer Chemother. Pharm."},{"key":"70066_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000087238","volume":"15","author":"BM Rotoli","year":"2005","unstructured":"Rotoli, B. M. et al. Inhibition of glutamine synthetase triggers apoptosis in asparaginase-resistant cells. Cell Physiol. Biochem. 15, 281\u2013292 (2005).","journal-title":"Cell Physiol. Biochem."},{"key":"70066_CR20","doi-asserted-by":"crossref","unstructured":"Guarecuco, R. et al. Dietary thiamine influences l-asparaginase sensitivity in a subset of leukemia cells. Sci. Adv. 6, eabc7120 (2020).","DOI":"10.1126\/sciadv.abc7120"},{"key":"70066_CR21","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cmet.2021.02.001","volume":"33","author":"AS Krall","year":"2021","unstructured":"Krall, A. S. et al. Asparagine couples mitochondrial respiration to ATF4 activity and tumor growth. Cell Metab. 33, 1013\u20131026 e1016 (2021).","journal-title":"Cell Metab."},{"key":"70066_CR22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1158\/2159-8290.CD-16-0441","volume":"7","author":"T Farge","year":"2017","unstructured":"Farge, T. et al. Chemotherapy-resistant human acute myeloid leukemia cells are not enriched for leukemic stem cells but require oxidative metabolism. Cancer Discov. 7, 716\u2013735 (2017).","journal-title":"Cancer Discov."},{"key":"70066_CR23","doi-asserted-by":"publisher","first-page":"41706","DOI":"10.18632\/oncotarget.5991","volume":"6","author":"C Denise","year":"2015","unstructured":"Denise, C. et al. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits. Oncotarget 6, 41706\u201341721 (2015).","journal-title":"Oncotarget"},{"key":"70066_CR24","doi-asserted-by":"publisher","first-page":"61890","DOI":"10.18632\/oncotarget.11301","volume":"7","author":"L Ippolito","year":"2016","unstructured":"Ippolito, L. et al. Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. Oncotarget 7, 61890\u201361904 (2016).","journal-title":"Oncotarget"},{"key":"70066_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11457","volume":"7","author":"AS Krall","year":"2016","unstructured":"Krall, A. S., Xu, S., Graeber, T. G., Braas, D. & Christofk, H. R. Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor. Nat. Commun. 7, 11457 (2016).","journal-title":"Nat. Commun."},{"key":"70066_CR26","doi-asserted-by":"publisher","first-page":"50829","DOI":"10.1074\/jbc.M409173200","volume":"279","author":"H Chen","year":"2004","unstructured":"Chen, H., Pan, Y. X., Dudenhausen, E. E. & Kilberg, M. S. Amino acid deprivation induces the transcription rate of the human asparagine synthetase gene through a timed program of expression and promoter binding of nutrient-responsive basic region\/leucine zipper transcription factors as well as localized histone acetylation. J. Biol. Chem. 279, 50829\u201350839 (2004).","journal-title":"J. Biol. Chem."},{"key":"70066_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13046-017-0648-4","volume":"36","author":"S Gao","year":"2017","unstructured":"Gao, S. et al. PSAT1 is regulated by ATF4 and enhances cell proliferation via the GSK3beta\/beta-catenin\/cyclin D1 signaling pathway in ER-negative breast cancer. J. Exp. Clin. Cancer Res. 36, 179 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"70066_CR28","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.molcel.2016.04.033","volume":"62","author":"R Riscal","year":"2016","unstructured":"Riscal, R. et al. Chromatin-bound MDM2 regulates serine metabolism and redox homeostasis independently of p53. Mol. Cell 62, 890\u2013902 (2016).","journal-title":"Mol. Cell"},{"key":"70066_CR29","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41556-019-0347-9","volume":"21","author":"F Tameire","year":"2019","unstructured":"Tameire, F. et al. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression. Nat. Cell Biol. 21, 889\u2013899 (2019).","journal-title":"Nat. Cell Biol."},{"key":"70066_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1035537","volume":"12","author":"D Bollino","year":"2022","unstructured":"Bollino, D. et al. Erwinia asparaginase (crisantaspase) increases plasma levels of serine and glycine. Front. Oncol. 12, 1035537 (2022).","journal-title":"Front. Oncol."},{"key":"70066_CR31","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nchembio.2070","volume":"12","author":"ME Pacold","year":"2016","unstructured":"Pacold, M. E. et al. A PHGDH inhibitor reveals coordination of serine synthesis and one-carbon unit fate. Nat. Chem. Biol. 12, 452\u2013458 (2016).","journal-title":"Nat. Chem. Biol."},{"key":"70066_CR32","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1073\/pnas.1521548113","volume":"113","author":"E Mullarky","year":"2016","unstructured":"Mullarky, E. et al. Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers. Proc. Natl. Acad. Sci. USA 113, 1778\u20131783 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70066_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.chembiol.2016.11.013","volume":"24","author":"Q Wang","year":"2017","unstructured":"Wang, Q. et al. Rational design of selective allosteric inhibitors of PHGDH and serine synthesis with anti-tumor activity. Cell Chem. Biol. 24, 55\u201365 (2017).","journal-title":"Cell Chem. Biol."},{"key":"70066_CR34","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1021\/acs.jmedchem.9b00718","volume":"62","author":"H Weinstabl","year":"2019","unstructured":"Weinstabl, H. et al. Intracellular trapping of the selective phosphoglycerate dehydrogenase (PHGDH) inhibitor BI-4924 disrupts serine biosynthesis. J. Med. Chem. 62, 7976\u20137997 (2019).","journal-title":"J. Med. Chem."},{"key":"70066_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30363-y","volume":"13","author":"N Kiweler","year":"2022","unstructured":"Kiweler, N. et al. Mitochondria preserve an autarkic one-carbon cycle to confer growth-independent cancer cell migration and metastasis. Nat. Commun. 13, 2699 (2022).","journal-title":"Nat. Commun."},{"key":"70066_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/msb.2012.20","volume":"8","author":"NA Graham","year":"2012","unstructured":"Graham, N. A. et al. Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death. Mol. Syst. Biol. 8, 589 (2012).","journal-title":"Mol. Syst. Biol."},{"key":"70066_CR37","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/2211-5463.12429","volume":"8","author":"M Hamano","year":"2018","unstructured":"Hamano, M. et al. Enhanced vulnerability to oxidative stress and induction of inflammatory gene expression in 3-phosphoglycerate dehydrogenase-deficient fibroblasts. FEBS Open Bio 8, 914\u2013922 (2018).","journal-title":"FEBS Open Bio"},{"key":"70066_CR38","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3389\/fgene.2018.00429","volume":"9","author":"E Zgheib","year":"2018","unstructured":"Zgheib, E. et al. Investigation of Nrf2, AhR, and ATF4 activation in toxicogenomic databases. Front. Genet. 9, 429 (2018).","journal-title":"Front. Genet."},{"key":"70066_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ccell.2020.06.001","volume":"38","author":"JD Hayes","year":"2020","unstructured":"Hayes, J. D., Dinkova-Kostova, A. T. & Tew, K. D. Oxidative stress in cancer. Cancer Cell 38, 167\u2013197 (2020).","journal-title":"Cancer Cell"},{"key":"70066_CR40","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41568-021-00435-0","volume":"22","author":"EC Cheung","year":"2022","unstructured":"Cheung, E. C. & Vousden, K. H. The role of ROS in tumour development and progression. Nat. Rev. Cancer 22, 280\u2013297 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"70066_CR41","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1083\/jcb.201804161","volume":"217","author":"A Bansal","year":"2018","unstructured":"Bansal, A. & Simon, M. C. Glutathione metabolism in cancer progression and treatment resistance. J. Cell Biol. 217, 2291\u20132298 (2018).","journal-title":"J. Cell Biol."},{"key":"70066_CR42","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","volume":"171","author":"A Reddy","year":"2017","unstructured":"Reddy, A. et al. Genetic and functional drivers of diffuse large B-cell lymphoma. Cell 171, 481\u2013494 e415 (2017).","journal-title":"Cell"},{"key":"70066_CR43","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019102147","volume":"38","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. SLC1A3 contributes to L-asparaginase resistance in solid tumors. EMBO J. 38, e102147 (2019).","journal-title":"EMBO J."},{"key":"70066_CR44","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.ccell.2019.03.004","volume":"35","author":"L Hinze","year":"2019","unstructured":"Hinze, L. et al. Synthetic lethality of Wnt pathway activation and asparaginase in drug-resistant acute leukemias. Cancer Cell 35, 664\u2013676 e667 (2019).","journal-title":"Cancer Cell"},{"key":"70066_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1021\/acsptsci.0c00196","volume":"4","author":"V Apfel","year":"2021","unstructured":"Apfel, V. et al. Therapeutic assessment of targeting ASNS combined with l-asparaginase treatment in solid tumors and investigation of resistance mechanisms. ACS Pharm. Transl. Sci. 4, 327\u2013337 (2021).","journal-title":"ACS Pharm. Transl. Sci."},{"key":"70066_CR46","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1182\/blood.2021011787","volume":"138","author":"M Butler","year":"2021","unstructured":"Butler, M. et al. BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway. Blood 138, 2383\u20132395 (2021).","journal-title":"Blood"},{"key":"70066_CR47","doi-asserted-by":"crossref","unstructured":"D\u2019Avola, A. et al. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. J. Clin. Investig. 132, e153436 (2022).","DOI":"10.1172\/JCI153436"},{"key":"70066_CR48","doi-asserted-by":"crossref","unstructured":"Hope, H. C. et al. Coordination of asparagine uptake and asparagine synthetase expression modulates CD8+ T cell activation. JCI Insight 6, e137761 (2021).","DOI":"10.1172\/jci.insight.137761"},{"key":"70066_CR49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41556-020-00615-4","volume":"23","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. Asparagine enhances LCK signalling to potentiate CD8(+) T-cell activation and anti-tumour responses. Nat. Cell Biol. 23, 75\u201386 (2021).","journal-title":"Nat. Cell Biol."},{"key":"70066_CR50","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/s42255-023-00856-1","volume":"5","author":"JNR Gnanaprakasam","year":"2023","unstructured":"Gnanaprakasam, J. N. R. et al. Asparagine restriction enhances CD8(+) T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response. Nat. Metab. 5, 1423\u20131439 (2023).","journal-title":"Nat. Metab."},{"key":"70066_CR51","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s42255-025-01245-6","volume":"7","author":"HC Chang","year":"2025","unstructured":"Chang, H. C. et al. Asparagine deprivation enhances T cell antitumour response in patients via ROS-mediated metabolic and signal adaptations. Nat. Metab. 7, 918\u2013927 (2025).","journal-title":"Nat. Metab."},{"key":"70066_CR52","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1093\/nar\/gkq1241","volume":"39","author":"CE Strom","year":"2011","unstructured":"Strom, C. E. et al. Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate. Nucleic Acids Res. 39, 3166\u20133175 (2011).","journal-title":"Nucleic Acids Res."},{"key":"70066_CR53","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1182\/blood.2021012805","volume":"139","author":"MA Galindo-Campos","year":"2022","unstructured":"Galindo-Campos, M. A. et al. Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice. Blood 139, 228\u2013239 (2022).","journal-title":"Blood"},{"key":"70066_CR54","doi-asserted-by":"publisher","first-page":"12351","DOI":"10.1093\/nar\/gkae811","volume":"52","author":"GA Elfar","year":"2024","unstructured":"Elfar, G. A. et al. p53-dependent crosstalk between DNA replication integrity and redox metabolism mediated through a NRF2-PARP1 axis. Nucleic Acids Res. 52, 12351\u201312377 (2024).","journal-title":"Nucleic Acids Res."},{"key":"70066_CR55","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1182\/bloodadvances.2022006965","volume":"6","author":"DC Ferguson","year":"2022","unstructured":"Ferguson, D. C. et al. Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia. Blood Adv. 6, 3386\u20133397 (2022).","journal-title":"Blood Adv."},{"key":"70066_CR56","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434, 913\u2013917 (2005).","journal-title":"Nature"},{"key":"70066_CR57","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917\u2013921 (2005).","journal-title":"Nature"},{"key":"70066_CR58","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ccell.2019.07.007","volume":"36","author":"S Parvin","year":"2019","unstructured":"Parvin, S. et al. LMO2 confers synthetic lethality to PARP inhibition in DLBCL. Cancer Cell 36, 237\u2013249 e236 (2019).","journal-title":"Cancer Cell"},{"key":"70066_CR59","doi-asserted-by":"publisher","first-page":"597","DOI":"10.21873\/anticanres.13989","volume":"40","author":"AD Ricci","year":"2020","unstructured":"Ricci, A. D. et al. Specific toxicity of maintenance olaparib versus placebo in advanced malignancies: a systematic review and meta-analysis. Anticancer Res. 40, 597\u2013608 (2020).","journal-title":"Anticancer Res."},{"key":"70066_CR60","doi-asserted-by":"publisher","first-page":"564601","DOI":"10.3389\/fcell.2020.564601","volume":"8","author":"M Rose","year":"2020","unstructured":"Rose, M., Burgess, J. T., O\u2019Byrne, K., Richard, D. J. & Bolderson, E. PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance. Front. Cell Dev. Biol. 8, 564601 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"70066_CR61","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/leu.2014.324","volume":"29","author":"J Chiche","year":"2015","unstructured":"Chiche, J. et al. GAPDH enhances the aggressiveness and the vascularization of non-Hodgkin\u2019s B lymphomas via NF-kappaB-dependent induction of HIF-1alpha. Leukemia 29, 1163\u20131176 (2015).","journal-title":"Leukemia"},{"key":"70066_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40170-020-00220-x","volume":"8","author":"M Pietzke","year":"2020","unstructured":"Pietzke, M. & Vazquez, A. Metabolite AutoPlotter - an application to process and visualise metabolite data in the web browser. Cancer Metab. 8, 15 (2020).","journal-title":"Cancer Metab."},{"key":"70066_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.chroma.2007.02.034","volume":"1147","author":"B Luo","year":"2007","unstructured":"Luo, B., Groenke, K., Takors, R., Wandrey, C. & Oldiges, M. Simultaneous determination of multiple intracellular metabolites in glycolysis, pentose phosphate pathway and tricarboxylic acid cycle by liquid chromatography-mass spectrometry. J. Chromatogr. A 1147, 153\u2013164 (2007).","journal-title":"J. Chromatogr. A"},{"key":"70066_CR64","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.1002\/cpbi.86","volume":"68","author":"J Chong","year":"2019","unstructured":"Chong, J., Wishart, D. S. & Xia, J. Using MetaboAnalyst 4.0 for comprehensive and integrative metabolomics data analysis. Curr. Protoc. Bioinforma. 68, e86 (2019).","journal-title":"Curr. Protoc. Bioinforma."},{"key":"70066_CR65","doi-asserted-by":"publisher","first-page":"W71","DOI":"10.1093\/nar\/gkq329","volume":"38","author":"J Xia","year":"2010","unstructured":"Xia, J. & Wishart, D. S. MSEA: a web-based tool to identify biologically meaningful patterns in quantitative metabolomic data. Nucleic Acids Res. 38, W71\u2013W77 (2010).","journal-title":"Nucleic Acids Res."},{"key":"70066_CR66","unstructured":"Nottet, N. NicolasNottet\/Article_ASNase-lymphosome_B_codes_R: Code and data for submitted article. (2025)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70066-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70066-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70066-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T11:04:53Z","timestamp":1775732693000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70066-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70066"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70066-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3305"}}